| Recruiting | Cancer Loyalty Card Study 2 (CLOCS-2) NCT06447064 | Imperial College London | — |
| Recruiting | A First-in-human Study of 3H-10000 in Patients With Unresectable or Metastatic Solid Tumors NCT07354711 | 3H Pharmaceuticals Co., Ltd. | Phase 1 / Phase 2 |
| Recruiting | Large Language Models Assist in Tumor MDT NCT07504367 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | N/A |
| Recruiting | Robotic Gastrectomy With 5th Arm NCT07310888 | Chinese University of Hong Kong | N/A |
| Not Yet Recruiting | Evaluation of the NEOmom® Gastric Video Capsule for Gastric Cancer Screening NCT07323186 | Nantes University Hospital | N/A |
| Recruiting | Ivonescimab in Comb. With FOLFOX in Advanced HER2 Neg. GEA NCT07070466 | Massachusetts General Hospital | Phase 2 |
| Recruiting | Total Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer NCT06028737 | Ukrainian Society of Clinical Oncology | Phase 2 / Phase 3 |
| Recruiting | Brodalumab in the Treatment of Immune-Related Adverse Events NCT06673329 | Brian Henick, MD | Phase 1 |
| Recruiting | Target-specific immunoPET Imaging of Digestive System Carcinoma NCT06715839 | RenJi Hospital | N/A |
| Recruiting | EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With NCT06263088 | Case Comprehensive Cancer Center | N/A |
| Recruiting | Avutometinib and Defactinib in Diffuse Gastric Cancer NCT06487221 | Ryan H. Moy, MD, PhD | Phase 2 |
| Completed | Enhanced Assistance During Radiotherapy for Unmet Essential Needs NCT06582849 | Washington University School of Medicine | N/A |
| Recruiting | TIL Therapy Combined With Pembrolizumab for Advanced or Metastatic Refractory Stomach and Esophageal Cancer NCT06532799 | Essen Biotech | Phase 1 / Phase 2 |
| Recruiting | Study of CEA Targeting CAR-T (PTC13) in the Treatment of CEA-Positive Advanced Malignant Solid Tumors NCT06821048 | Weijia Fang, MD | Phase 1 |
| Unknown | Postoperative Morbidity and Mortality After Gastric Cancer Surgery NCT06277908 | P. Herzen Moscow Oncology Research Institute | — |
| Recruiting | Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With NCT06199895 | Liu Huang | Phase 2 |
| Completed | Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal NCT07387237 | Unidade Local De Saúde Do Norte Alentejano | — |
| Recruiting | CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esoph NCT05187182 | Washington University School of Medicine | Phase 1 |
| Completed | Pilot Study of the eHealth Application "Cancer Patients Better Life Experience" (CAPABLE) - Italy NCT06161233 | Istituti Clinici Scientifici Maugeri SpA | N/A |
| Withdrawn | GI Organ Tracking Via Balloon Applicators NCT05471401 | Washington University School of Medicine | N/A |
| Terminated | A Study of IMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HE NCT05311176 | Imugene Limited | Phase 2 |
| Completed | Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients NCT05638048 | Junyan Zhao | N/A |
| Completed | Effects of Red Ginseng on Gastrointestinal Symptoms and Microbiota After Surgery for Gastrointestinal Cancer NCT06561516 | Gangnam Severance Hospital | N/A |
| Recruiting | Development and Demonstration of Intelligent Assessment Based on Multi-modal Information Fusion for Tumor Risk NCT06653478 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Recruiting | Artificial Intelligence System for Assessment of Tumor Risk and Diagnosis and Treatment NCT05426135 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | — |
| Completed | A Clinical Study of CEA-targeted CAR-T in the Treatment of CEA-positive Advanced Malignant Solid Tumors NCT05396300 | Weijia Fang, MD | Phase 1 |
| Recruiting | cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease NCT05366881 | Adela, Inc | — |
| Recruiting | KN026 in Combination With Chemotherapy in HER2 Positive Gastric Cancer Subjects Who Have Failed First-line The NCT05427383 | Shanghai JMT-Bio Inc. | Phase 2 / Phase 3 |
| Recruiting | XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esopha NCT05494060 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Completed | Development of Free DNA Multi-target Methylated PCR for Auxiliary Diagnosis of Gastric Cancer NCT05336058 | Singlera Genomics Inc. | — |
| Unknown | Total Versus Partial Omentectomy in the Treatment of Gastric Cancer NCT05238584 | University of Debrecen | N/A |
| Unknown | Study of Perioperative Chemotherapy Combined With Tislelizumab and Trastuzumab in the Treatment of GC/EGC NCT04819971 | The First Affiliated Hospital of Zhengzhou University | Phase 2 |
| Recruiting | Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes NCT04907643 | Cedars-Sinai Medical Center | N/A |
| Unknown | Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors NCT05415475 | Chongqing Precision Biotech Co., Ltd | Phase 1 |
| Recruiting | Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Typ NCT04890171 | National Cancer Center, Korea | N/A |
| Completed | The Registry of Oncology Outcomes Associated With Testing and Treatment NCT04028479 | Taproot Health | — |
| Completed | PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers NCT05697198 | Labcorp Corporation of America Holdings, Inc | — |
| Unknown | The Effect of Immunological Heterogeneity of Tumor Microenvironment in the Prognosis of Gastric Cancer NCT04819958 | Fujian Medical University | — |
| Completed | DNA Evaluation of Fragments for Early Interception - Lung Cancer Training Study (DELFI-L101 Study) NCT04825834 | Delfi Diagnostics Inc. | — |
| Completed | Docetaxel and Irinotecan in Gastric Cancer NCT04770623 | Menoufia University | Phase 2 |
| Active Not Recruiting | Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer NCT05931445 | Comprehensive Support Project for Oncology Research | N/A |
| Completed | Does Coronavirus Disease 2019 (COVID-19) Pandemic Cause a Delay in the Diagnosis of Gastric Cancer Patients? NCT04797624 | Adana City Training and Research Hospital | — |
| Unknown | Neoadjuvant Chemotherapy With PISOXO for Locally-invaded-gastric Cancer (LIGC) NCT04410887 | Ruijin Hospital | Phase 1 / Phase 2 |
| Terminated | The PLATON Network NCT05489250 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | — |
| Completed | PLATON - Platform for Analyzing Targetable Tumor Mutations (Pilot-study) NCT04484636 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | N/A |
| Unknown | HX008 Plus Irinotecan Versus Placebo Plus Irinotecan as Second-line Treatment in Advanced Gastric Cancer NCT04486651 | Taizhou Hanzhong biomedical co. LTD | Phase 3 |
| Unknown | Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer NCT04526470 | Seoul National University Bundang Hospital | Phase 1 / Phase 2 |
| Completed | Effect of Mosapride Citrate on Gastrointestinal Motility After Laparoscopic Gastrectomy NCT04493125 | Gangnam Severance Hospital | N/A |
| Completed | A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene E NCT04426669 | Intima Bioscience, Inc. | Phase 1 / Phase 2 |
| Unknown | Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer NCT04135781 | Zhejiang Cancer Hospital | Phase 3 |
| Withdrawn | An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Ther NCT03704077 | Bristol-Myers Squibb | Phase 2 |
| Unknown | Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy NCT04215861 | The First Affiliated Hospital of Dalian Medical University | — |
| Unknown | A Clinical Trial to Evaluate Safety and Efficacy of Endovascualr Denervation in Treatment of Cancer Pain NCT04014478 | Shanghai Golden Leaf MedTec Co. Ltd | N/A |
| Completed | The Effect of Deep Neuromuscular Block on the Perioperative Stress Response Reduction and Postoperative Recove NCT03937440 | Yonsei University | N/A |
| Unknown | AZD8186 and Paclitaxel in Advanced Gastric Cancer NCT04001569 | Seoul National University Bundang Hospital | Phase 1 / Phase 2 |
| Withdrawn | Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 NCT03644459 | Lynkcell Inc. | Phase 1 |
| Unknown | A Phase II Trial of Neoadjuvant Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) With Chemoradia NCT04308837 | Icahn School of Medicine at Mount Sinai | Phase 2 |
| Active Not Recruiting | Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junct NCT03760822 | Federation Francophone de Cancerologie Digestive | Phase 2 |
| Completed | A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies NCT03652077 | Incyte Corporation | Phase 1 |
| Completed | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors NCT03662204 | Exact Sciences Corporation | — |
| Active Not Recruiting | Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma NCT03488667 | University of Kansas Medical Center | Phase 2 |
| Completed | Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy NCT03515356 | University of Michigan Rogel Cancer Center | N/A |
| Completed | Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers NCT03604653 | Holy Name Medical Center, Inc. | — |
| Active Not Recruiting | Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer NCT03448835 | The Netherlands Cancer Institute | Phase 2 |
| Unknown | A Phase I Study of High Dose Simvastatin in Patients With Gastrointestinal Tract Cancer Who Failed to Standard NCT03086291 | Samsung Medical Center | Phase 1 |
| Unknown | A Randomized Phase II Open Label Study to Compare the Safety and Efficacy of Subcutaneous Dalteparin Versus Di NCT03139487 | Asan Medical Center | Phase 2 |
| Completed | Discovery and Validation of Plasma DNA Methylation Biomarker for Detection of Stomach Cancer NCT03076567 | National Cancer Institute (NCI) | — |
| Completed | Prospective Evaluation and Molecular Profiling in People With Gastric Tumors NCT03027427 | National Cancer Institute (NCI) | — |
| Completed | Hereditary Gastric Cancer Syndromes: An Integrated Genomic and Clinicopathologic Study of the Predisposition t NCT03030404 | National Cancer Institute (NCI) | — |
| Withdrawn | A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of NCT02943603 | Weijing Sun, MD, FACP | Phase 2 |
| Completed | The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignanci NCT03384511 | Shandong Cancer Hospital and Institute | Phase 4 |
| Completed | Programs To Support You During Chemotherapy NCT02489422 | Wake Forest University Health Sciences | N/A |
| Completed | FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) NCT02661971 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 2 / Phase 3 |
| Completed | FLOT vs. FLOT/Herceptin/Pertuzumab for Perioperative Therapy of HER-2 Expressing Gastric or GEJ Cancer NCT02581462 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 2 / Phase 3 |
| Completed | Combination Margetuximab and Pembrolizumab for Advanced, Metastatic HER2(+) Gastric or Gastroesophageal Juncti NCT02689284 | MacroGenics | Phase 1 / Phase 2 |
| Completed | Effect of Modified Stylet Angulation on the Intubation With GlideScope® NCT02547064 | Keimyung University Dongsan Medical Center | N/A |
| Completed | The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Correct NCT02604979 | Yonsei University | — |
| Terminated | S-1/Oxaliplatin for High Risk Patients Who Underwent Gastrectomy NCT02191566 | Kangbuk Samsung Hospital | Phase 2 |
| Unknown | A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA NCT03057171 | Yonsei University | — |
| Unknown | Fish Oil Supplementation in Gastrointestinal Cancer NCT02699047 | Universidade Federal de Santa Catarina | N/A |
| Terminated | Effects of S-1 and Capecitabine on Coronary Artery Blood Flow NCT02216149 | Heikki Joensuu | Phase 2 |
| Withdrawn | KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer NCT02205463 | NYU Langone Health | Phase 1 |
| Unknown | Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia NCT02325323 | Assistance Publique - Hôpitaux de Paris | — |
| Terminated | Validation of MMS Test for Cancer Monitoring NCT02113683 | MedInnovation GmbH | — |
| Terminated | A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus NCT01774851 | Merrimack Pharmaceuticals | Phase 2 |
| Completed | Comparison of O-type Hybrid Knife and IT Knife in ESD NCT01760070 | Xijing Hospital of Digestive Diseases | N/A |
| Completed | Perceptions of Exceptional Patients in Cancer Care Relating to Their Unusual Survival NCT02055313 | Meir Medical Center | — |
| Unknown | Trial of Adjuvant Chemotherapy for High Risk Gastric Cancer Patients NCT01618474 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Completed | Effect of Erythromycin Before Endoscopy of Patients With Subtotal Gastrectomy (STG), High Risk of Gastric Stas NCT01659619 | The Catholic University of Korea | Phase 2 |
| Completed | A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer NCT01246960 | Eli Lilly and Company | Phase 2 |
| Unknown | EUFURO - EUS-based Follow-Up on R0-resected Patients for Esophageal, Gastric and Pancreatic Cancer NCT02209415 | Michael Bau Mortensen | N/A |
| Unknown | Development of a Versatile Intra-operative On-screen Audiovisual Mentoring System Using TileproTM Program for NCT01319084 | Yonsei University | — |
| Completed | Cancer in Patients With Gabapentin (GPRD) NCT01236053 | GlaxoSmithKline | — |
| Unknown | The Use of Ultrasonic Coagulating Shears Compared to Monopolar Electrocautery in Open Gastric Cancer Surgery NCT01179750 | Samsung Medical Center | Phase 3 |
| Unknown | Study to Evaluate the Efficacy of Pravastatin on Survival and Recurrence of Advanced Gastroesophageal Cancer NCT01038154 | Hospital Donostia | Phase 4 |
| Unknown | A Study With Health Educational Material on Health Promotion in Cancer Survivors NCT00948337 | National Cancer Center, Korea | Phase 2 |
| Completed | Cisplatin, Irinotecan and Bevacizumab (PCA) Versus Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in NCT00911820 | Dana-Farber Cancer Institute | Phase 2 |
| Terminated | Comparison of Standard of Care or Treatment on Protocol NCT01010334 | New Mexico Cancer Research Alliance | N/A |
| Completed | Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma NCT00780494 | Stanford University | Phase 2 |
| Completed | A Study Comparing Billroth II With Roux-en-Y Reconstruction for Gastric Cancer NCT01257711 | National Healthcare Group, Singapore | N/A |
| Withdrawn | Prospective Evaluation of the Preoperative Lymph Node Staging in Patients With Cancer of the Esophagogastric J NCT00800969 | University of Zurich | Phase 2 |
| Terminated | Study to Evaluate Combination Treatment of MGCD0103 and Docetaxel (Taxotere®) for Subjects With Advanced Cance NCT00511576 | Mirati Therapeutics Inc. | Phase 1 |
| Withdrawn | Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy NCT00622804 | The Catholic University of Korea | Phase 3 |
| Terminated | A Study of Vinflunine in Patients With Gastric Cancer NCT00359476 | Bristol-Myers Squibb | Phase 2 / Phase 3 |
| Terminated | Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers NCT01445327 | National Cancer Institute (NCI) | — |
| Completed | Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer NCT00394433 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer NCT00446290 | Asan Medical Center | Phase 1 |
| Completed | Safety and Immunogenicity of CHP-HER2 and CHP-NY-ESO-1 Protein With OK-432 in Antigen-Expressing Cancers NCT00291473 | Ludwig Institute for Cancer Research | Phase 1 |
| Completed | Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastri NCT00857246 | NYU Langone Health | Phase 2 |
| Completed | Metastatic Gastric Cancer FFCD 03-07 NCT00374036 | University Hospital, Toulouse | Phase 3 |
| Completed | Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) NCT00525785 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-In NCT01016639 | Lund University Hospital | Phase 1 / Phase 2 |
| Completed | Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer NCT00858338 | NYU Langone Health | Phase 2 |
| Recruiting | Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma NCT01048281 | Stanford University | — |
| Completed | Trial of Adjuvant Chemotherapy for Gastric Cancer NCT00296335 | Asan Medical Center | Phase 3 |
| Completed | Trial of Adjuvant Chemotherapy for Gastric Cancer NCT00296322 | Asan Medical Center | Phase 3 |
| Completed | Sequentially Administered CPT-11 and Mitomycin C in Patients With Advanced Esophageal and Stomach Cancer NCT00201747 | Ohio State University Comprehensive Cancer Center | Phase 2 |
| Completed | Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma NCT00215514 | Dana-Farber Cancer Institute | EARLY_Phase 1 |
| Completed | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma NCT00215462 | Dana-Farber Cancer Institute | Phase 2 |
| Completed | A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women NCT00342004 | National Cancer Institute (NCI) | — |